Ventrus Bio (VTUS) Type B pre-NDA Meeting Set for DOLIZEM
Tweet Send to a Friend
Ventrus Biosciences, Inc. (Nasdaq: VTUS) announced that, in response to a request from the company, the U.S. Food ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE